Search results
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
ABC 26 New Orleans· 5 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
Sunday Shows preview: College protests heat up nationwide, Noem faces backlash
The Hill via AOL· 1 day agoThe political tension around the ever-growing pro-Palestinian protests on college campuses will...
Biden White House signals pessimism about election in surprising way
Fox News· 6 days agoNEWYou can now listen to Fox News articles! It’s not just atrocious polls that suggest President Joe...
Pioneer Natural Resources co-founder will be barred from board in deal for Exxon merger
Dallas Morning News· 4 days agoThe Federal Trade Commission is poised to greenlight Exxon Mobil’s $60 billion purchase of...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 5 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
FTC Challenges 'Bogus' Patents on Ozempic and Other Drugs
MedPage Today· 5 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...